You are hereHome CategoriesJordan
Tabuk Pharmaceuticals signs license and supply agreement with Selectchemie
Source: PRNewswire , Author: Posted by BI-ME staff
Posted: Fri October 6, 2017 11:56 am

JORDAN. -- /PRNewswire/ -- Tabuk Pharmaceutical Manufacturing Company ("Tabuk"), one of the leading pharmaceutical companies in the Middle East and North Africa (MENA) region, has entered into an agreement with Selectchemie, under which Selectchemie granted Tabuk a license to register, market and sell Caspofungin Injection (systemic antifungal agent) in Saudi Arabia, the Gulf Countries, North Africa, and the rest of Middle East.

Selectchemie is one of the leading European companies, headquartered in Zurich serving the pharmaceutical and human nutrition industries since 1969 as a premier supplier of high quality ingredients.

Dr. Rana Azzam, Senior VP of Business Development said "We are excited about this major partnership collaboration with Selectchemie. Caspofungin Injection is a hard to develop and lifesaving product. This partnership will provide an opportunity for both companies to leverage their combined strength."

Selectchemie side commented "Dr. Peter Kaufmann, CEO of Selectchemie, is proud to have gained Tabuk Pharmaceutical Manufacturing Company as a licensing and marketing partner for Caspofungin in the MENA Region. With this highest quality product, manufactured in Europe, Selectchemie looks forward to a long-term partnership with Tabuk to the benefit of both companies and end-users."

 

MIDDLE EAST BUSINESS COMMENT & ANALYSIS

date:Posted: December 10, 2018
UAE. After fantastic returns in 2017 everywhere, 2018 is a sea of red; Volatility rules, despite objective good news on the political front; Patience recommended as markets undershoot fundamentals.
date:Posted: December 10, 2018
UAE. Retail sales across four Gulf countries are projected to increase by more than US$24 billion over the next five years, according to new research from Euromonitor International; UAE's US$55 billion retail industry forecast to grow 16% by 2023.
date:Posted: December 9, 2018
UAE. When asked about their motivation for a new career, the most common reason was "to find their real passion" (57.7%), followed by “better compensation” (18.1%).
dhgate